IXJ vs. FTXH
IXJ (iShares Global Healthcare ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) are both Health & Biotech Equities funds - IXJ tracks the S&P Global 1200 Health Care (Sector) Capped Index while FTXH tracks the Nasdaq U.S. Smart Pharmaceuticals Index. Both are passively managed. Over the past 5 years, IXJ returned 4.53%/yr vs 9.58%/yr for FTXH. Their 0.72 correlation means they have sometimes moved together and sometimes differently. IXJ charges 0.40%/yr vs 0.60%/yr for FTXH.
Performance
IXJ vs. FTXH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IXJ achieves a 3.85% return, which is significantly lower than FTXH's 18.55% return.
IXJ
- 1D
- -0.97%
- 1M
- -1.26%
- 6M
- 2.41%
- YTD
- 3.85%
- 1Y
- 21.78%
- 3Y*
- 7.07%
- 5Y*
- 4.53%
- 10Y*
- 8.22%
- ALL TIME*
- 7.37%
FTXH
- 1D
- -1.05%
- 1M
- -0.66%
- 6M
- 15.17%
- YTD
- 18.55%
- 1Y
- 50.60%
- 3Y*
- 15.55%
- 5Y*
- 9.58%
- 10Y*
- —
- ALL TIME*
- 8.11%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $132.14M | $63.96M | $21.87M | |
| $16.06M | $16.61M | $23.38M |
IXJ vs. FTXH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | 3.85% | 14.99% | 0.55% | 3.62% | -4.94% | 19.60% | 12.74% | 23.23% | 2.83% | 20.44% |
FTXH First Trust Nasdaq Pharmaceuticals ETF | 18.55% | 24.15% | 2.98% | -1.41% | 2.55% | 6.14% | 11.73% | 22.13% | -9.51% | 19.44% |
Correlation
The correlation between IXJ and FTXH is 0.88, meaning they have usually moved in the same direction, including during past declines.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.88 |
Correlation (3Y) Balances recent behavior with more history. | 0.84 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.82 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2016 | 0.72 |
The correlation between IXJ and FTXH shifts across timeframes, from 0.72 (all time) to 0.88 (1 year), reflecting how their relationship changes across market environments.
IXJ vs. FTXH - Sectors Allocation Comparison
Sectors
IXJ
FTXH
Healthcare
Consumer Defensive
-
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
IXJ
FTXH
Consumer Defensive
IXJ
FTXH
-
Technology
IXJ
FTXH
-
Basic Materials
IXJ
-
FTXH
-
Communication Services
IXJ
-
FTXH
-
Consumer Cyclical
IXJ
-
FTXH
-
Energy
IXJ
-
FTXH
-
Financial Services
IXJ
-
FTXH
-
Industrials
IXJ
-
FTXH
-
Real Estate
IXJ
-
FTXH
-
Utilities
IXJ
-
FTXH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. FTXH — Risk / Return Rank
IXJ
FTXH
IXJ vs. FTXH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and First Trust Nasdaq Pharmaceuticals ETF (FTXH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IXJ | FTXH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.62 | ||
| Sortino ratioReturn per unit of downside risk | -2.18 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.52 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | 2.10 | 7.13 | -5.03 |
| Martin ratioReturn relative to average drawdown | 4.99 | 21.24 | -16.25 |
Loading charts...
Drawdowns
IXJ vs. FTXH - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, which is greater than FTXH's maximum drawdown of -32.11%. Use the drawdown chart below to compare losses from any high point for IXJ and FTXH.
Loading charts...
Drawdown Indicators
| IXJ | FTXH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -32.11% | -8.49% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | -7.47% | -3.31% |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | -19.51% | +1.37% |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | -19.51% | +1.37% |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | — | — |
Current DrawdownCurrent decline from peak | -2.52% | -2.01% | -0.51% |
Average DrawdownAverage peak-to-trough decline | -6.90% | -5.76% | -1.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.52% | 2.50% | +2.02% |
Volatility
IXJ vs. FTXH - Volatility Comparison
iShares Global Healthcare ETF (IXJ) and First Trust Nasdaq Pharmaceuticals ETF (FTXH) have volatilities of 5.66% and 5.56%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IXJ | FTXH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.66% | 5.56% | +0.10% |
Volatility (6M)Calculated over the trailing 6-month period | 11.61% | 12.78% | -1.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.38% | 17.21% | -1.83% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.50% | 16.53% | -2.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.74% | 18.43% | -2.69% |
IXJ vs. FTXH - Expense Ratio Comparison
IXJ has a 0.40% expense ratio, which is lower than FTXH's 0.60% expense ratio.
Dividends
IXJ vs. FTXH - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.44%, more than FTXH's 1.09% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FTXH First Trust Nasdaq Pharmaceuticals ETF | 1.09% | 1.41% | 1.66% | 1.55% | 1.11% | 1.03% | 0.82% | 0.67% | 0.91% | 2.18% | 0.19% | 0.00% |
IXJ iShares Global Healthcare ETF | 1.44% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
Frequently Asked Questions
IXJ and FTXH have a correlation of 0.88, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IXJ has higher volatility (5.66%) compared to FTXH (5.56%). In terms of maximum drawdown, IXJ dropped -40.60% vs FTXH's -32.11%.
On 5-year performance, FTXH leads with 9.58% vs 4.53% for IXJ. On fees, IXJ is cheaper at 0.40% per year. On volatility, FTXH has been the lower-risk option at 5.56%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FTXH has performed better with a 9.58% return vs 4.53%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IXJ is cheaper with a 0.40% expense ratio, compared with 0.60% for FTXH.
IXJ has the higher dividend yield at 1.44%, compared with 1.09% for FTXH.
IXJ tracks S&P Global 1200 Health Care (Sector) Capped Index, while FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index. They also come from different issuers: iShares and First Trust. Their fees differ too: 0.40% for IXJ and 0.60% for FTXH.
FTXH currently has the higher Sharpe Ratio (3.12 vs 1.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IXJ and FTXH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer